C5orf46 and pancreatic adenocarcinoma: Similarly, previous studies suggested a pro-tumoral and prognostic role of C5ORF46 in several GI tumors, including PAAD (Makler and Narayanan, 2017), COAD (Chen et al., 2021), and STAD (Cheng et al., 2020).